Clinical Trial Update: Levobetaxolol Hydrochloride Eye Drops for Treatment of Primary Open-angle Glaucoma or Ocular Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial update for Levobetaxolol Hydrochloride Eye Drops in primary open-angle glaucoma and ocular hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Levobetaxolol Hydrochloride Eye Drops (levobetaxolol hydrochloride)

Snippet

Sponsor: Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. | Conditions: Primary Open-angle Glaucoma, Ocular Hypertension | Phase 3 | Status: COMPLETED